Editor’s note: Bankruptcies are listed in chronological order.
- Florida drugmaker files for bankruptcy after recall
KRS Global Biotechnology, a Boca Raton, Fla.-based drug-compounding facility, filed for Chapter 11 bankruptcy, citing “unforeseen business circumstances.” - Insys bankruptcy plan gets court OK
Insys Therapeutics, the first drugmaker to go bankrupt after opioid litigation, won court approval for its bankruptcy plan Jan. 16. - Reva Medical files for bankruptcy
Reva Medical, a San Diego-based devicemaker that specializes in vascular devices, has filed for Chapter 11 bankruptcy, listing $5.9 million in assets and $104.5 million in debt. - Insulin pump maker files for bankruptcy
Valeritas Holdings, a New Jersey-based company that makes insulin pumps, filed for Chapter 11 bankruptcy, and Zealand Pharma, a Denmark-based drugmaker, said it will acquire “substantially all” of Valeritas’ assets. - Mallinckrodt to put US generics business in bankruptcy in opioid settlement
Mallinckrodt filed for Chapter 11 bankruptcy for its generic drug business as part of a settlement with 47 U.S. states and U.S. territories. - Generic drugmaker Akorn files for bankruptcy
Akorn, a generic drugmaker based in Lake Forest, Ill., has filed for Chapter 11 bankruptcy a year after the FDA sent it warning letters about manufacturing violations at two of its plants.
More articles on pharmacy:
Generic remdesivir to cost up to $79 per dose
GlaxoSmithKline recalls 2 cough syrups with wrong dosing cups
CVS partners with American Lung Association for COVID-19 research effort
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
